Cited by 960Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionCholesterol and Lipid Metabolism

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

Open access
Muldoon, M F, Manuck, S B, Matthews, K A·1990·BMJ

Abstract

OBJECTIVE: To determine the effects of lowering cholesterol concentrations on total and cause specific mortality in randomised primary prevention trials. DESIGN: Qualitative (meta-analytic) evaluation of total mortality from coronary heart disease, cancer, and causes not related to illness in six primary prevention trials of cholesterol reduction (mean duration of treatment 4.8 years). PATIENTS: 24,847 Male participants; mean age 47.5 years. MAIN OUTCOME MEASURES: Total and cause specific mortalities. RESULTS: Follow up periods totalled 119,000 person years, during which 1147 deaths occurred. Mortality from coronary heart disease tended to be lower in men receiving interventions to reduce cholesterol concentrations compared with mortality in control subjects (p = 0.06), although total mortality was not affected by treatment. No consistent relation was found between reduction of cholesterol concentrations and mortality from cancer, but there was a significant increase in deaths not related to illness (deaths from accidents, suicide, or violence) in groups receiving treatment to lower cholesterol concentrations relative to controls (p = 0.004). When drug trials were analysed separately the treatment was found to reduce mortality from coronary heart disease significantly (p = 0.04). CONCLUSIONS: The association between reduction of cholesterol concentrations and deaths not related to illness warrants further investigation. Additionally, the failure of cholesterol lowering to affect overall survival justifies a more cautious appraisal of the probable benefits of reducing cholesterol concentrations in the general population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.301.6747.309

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Study Group of the European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. EurHeartJ 1987;8:77-88.
  2. Lipid Research Clinics Program. The Lipid Research Clinics coronary primary prevention trial results. jAMA 1984;251:351-74.
  3. Frantz ID, Dawson EA, Ashman PL, et al. Test of effect of lipid lowering by diet on cardiovascular risk. Arteriosclerosis 1989;9:129-35.
  4. Kaplan JR, Manuck SB. The effects of fat and cholesterol on aggressive behaviour in monkeys [Abstract]. Psychosom Med 1990;52:226-7.

Cited by

Sorted by citations

Authors
Muldoon, M. F., Manuck, S. B., & Matthews, K. A.
Affiliations
University of Pittsburgh (US)
Venue
BMJ
Publisher
BMJ
Published
1990-08-11
Volume
301
Issue
6747
Pages
309-314
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W1984058728
Cited by
960
References
47
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 14 · 2016: 9 · 2015: 12 · 2014: 14 · 2013: 14 · 2012: 14
FWCI
20.33
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (#HL07560, HL 40962, P01HL040962)
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
cholesterol lowering, hypercholesterolemia, mortality, coronary heart disease mortality, cancer mortality, primary prevention, statins, drug trials
MeSH terms
Aged, Anticholesteremic Agents, Cause of Death, Cholesterol, Coronary Disease, Diet, Humans, Male, Middle Aged, Mortality, Neoplasms, Primary Prevention, Meta-Analysis as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review